Breakthrough in Parent Company Liability

The Transitioning Medical Professional Liability Market—Challenges in Valuing a Medical Professional Liability Company

Likely driven by continuing health reform efforts and the flight of physicians from administrative detail and operating risk, statistics indicate that the number of physicians in private practice has declined notably over the past 10 years. By the time the Affordable Care Act was upheld by the U.S. Supreme Court on June 28, 2012, at least one industry source was estimating that the number of ph...

high volatility, thick tails and extreme value theory in value at risk estimation: the case of liability insurance in iran insurance company

در این بررسی ابتدا به بررسی ماهیت توزیع خسارات پرداخته میشود و از روش نظریه مقادیر نهایی برای بدست آوردن برآورد ارزش در معرض خطر برای خسارات روزانه بیمه مسئولیت شرکت بیمه ایران استفاده میشود. سپس کارایی نظریه مقدار نهایی در برآورد ارزش در معرض خطر با کارایی سایر روشهای واریانس ، کواریانس و روش شبیه سازی تاریخی مورد مقایسه قرار میگیرد. نتایج این بررسی نشان میدهند که توزیع ،garch شناخته شده مدل...

Consumer Reliance on Statements About Pre-Existing Condition Coverage Creates Potential Liability for Insurance Company

The Hosfords consequently sued State Termite and the Inspector alleging negligence and several other theories of recovery. In the Circuit Court of Lowndes County, Mississippi, State Termite did not deny that a pest control operator is held to a duty of reasonable care similar to that imposed upon anyone providing expert or specialized services to the public. Rather, State Termite claimed there ...

A stochastic programming model for asset liability management of a Finnish pension company

This paper describes a stochastic programming model that was developed for asset liability management of a Finnish pension insurance company. In many respects the model resembles those presented in the literature, but it has some unique features stemming from the statutory restrictions for Finnish pension insurance companies. Particular attention is paid to modeling the stochastic factors, nume...

Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.